A
Alagappan
About Alagappan
Data last updated:
Alagappan is a Director at Steril-Gene Life Sciences Private Limited (since 2014), Director at Madras Pharma Holdings Private Limited (since 2025) and Director at Anphar Organics Private Limited (since 2014), and holds 3 more current directorships. The companies operate in Pharma and Financial Services. The 5 current companies with reported revenue have a combined latest revenue of ₹509 Cr; the largest is Steril-Gene Life Sciences Private Limited at ₹404 Cr (FY 2025). Earlier, Alagappan was a Director at Softgel Healthcare Private Limited (2014–2022).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Steril-Gene Life Sciences Private Limited U02423TN2007PTC062549 | Director | 10 Mar 2014 | 2007 | ₹404 Cr (FY 2025) | Active |
 Madras Pharma Holdings Private Limited U65990TN2010PTC075670 | Director | 17 Mar 2025 | 2010 | ₹43.68 Cr (FY 2025) | Active |
| Anphar Organics Private Limited U24231JK1994PTC001409 | Director | 07 Aug 2014 | 1994 | ₹36.70 Cr (FY 2025) | Active |
| Sunberg Life Sciences Private Limited U51397TN2015PTC099067 | Director | 17 Mar 2025 | 2015 | ₹24.43 Cr (FY 2025) | Active |
| Maral Health Care Private Limited U24231TN2004PTC052943 | Director | 10 Mar 2014 | 2004 | ₹1.2 Lakh (FY 2025) | Active |
 Madras Pharmaceuticals Private Limited U24233TN2015PTC100449 | Director | 11 May 2015 | 2015 | Active |
Previous companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Softgel Healthcare Private Limited U24231TN2003PTC051829 | Director | 10 Mar 2014 | 2003 | ₹327 Cr (FY 2025) | Active |
Explore Director's current and past company associations Uncover their professional journey today!
Board colleagues of Alagappan
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Alagappan
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Alagappan
Alagappan currently holds 6 directorships: Steril-Gene Life Sciences Private Limited (Director, since 10 Mar 2014, revenue ₹404 Cr (FY 2025)); Madras Pharma Holdings Private Limited (Director, since 17 Mar 2025, revenue ₹43.68 Cr (FY 2025)); Anphar Organics Private Limited (Director, since 07 Aug 2014, revenue ₹36.70 Cr (FY 2025)); Sunberg Life Sciences Private Limited (Director, since 17 Mar 2025, revenue ₹24.43 Cr (FY 2025)); Maral Health Care Private Limited (Director, since 10 Mar 2014, revenue ₹1.2 Lakh (FY 2025)); and 1 more.
Alagappan was first appointed on 10 Mar 2014 as Director at Steril-Gene Life Sciences Private Limited. The most recent appointment on record is 17 Mar 2025 at Sunberg Life Sciences Private Limited.
The 5 current companies of Alagappan that report revenue have a combined latest revenue of ₹509 Cr: Steril-Gene Life Sciences Private Limited ₹404 Cr (FY 2025); Madras Pharma Holdings Private Limited ₹43.68 Cr (FY 2025); Anphar Organics Private Limited ₹36.70 Cr (FY 2025); Sunberg Life Sciences Private Limited ₹24.43 Cr (FY 2025); Maral Health Care Private Limited ₹1.2 Lakh (FY 2025).
Alagappan held 1 earlier board appointment: Softgel Healthcare Private Limited (Director, 10 Mar 2014 to 08 Sep 2022).
The current boards of Alagappan's companies include Chanpreet Singh Anand (Steril-Gene Life Sciences Private Limited), Dennis Dizon Balajadia (Steril-Gene Life Sciences Private Limited), Dick Dizon Balajadia (Steril-Gene Life Sciences Private Limited), Lloyd Dizon Balajadia (Steril-Gene Life Sciences Private Limited), Manohar Srivignesh (Steril-Gene Life Sciences Private Limited), Maximo Ponce Balajadia (Steril-Gene Life Sciences Private Limited), among others.